|
|
||||||||
MRI slice templates of rhesus monkey brain (top), corresponding PET slices acquired using 18F-nifrolidine (middle), and axial summed PET slices showing the distribution of 18F-nifrolidine (bottom). Nifrolidine is being evaluated as a PET agent for nicotine α4β2 receptor subtypes, which have been implicated in the study of Alzheimer's disease, schizophrenia, substance abuse, lung cancer, and other disorders.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |